Rocco Liguori Selected Research

Hereditary Sensory and Autonomic Neuropathy Type Ie

1/2020

DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rocco Liguori Research Topics

Disease

12	Narcolepsy 09/2022 - 12/2008
12	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2014
9	Fabry Disease (Fabry's Disease) 01/2022 - 01/2014
9	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2009
6	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2022 - 01/2008
6	Parkinsonian Disorders (Parkinsonism) 01/2022 - 04/2014
6	Dementia (Dementias) 04/2018 - 04/2014
5	Synucleinopathies 05/2022 - 05/2017
5	Optic Atrophy 01/2022 - 02/2008
5	Small Fiber Neuropathy 01/2018 - 04/2011
4	Optic Nerve Diseases (Optic Neuropathy) 07/2015 - 02/2008
4	Peripheral Nervous System Diseases (PNS Diseases) 07/2015 - 02/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2021
3	Pain (Aches) 10/2021 - 01/2016
3	Brain Diseases (Brain Disorder) 08/2021 - 01/2013
3	Myasthenia Gravis 04/2021 - 06/2019
3	Cognitive Dysfunction 01/2021 - 07/2015
3	Atrophy 01/2021 - 03/2006
3	Orthostatic Hypotension (Postural Hypotension) 01/2020 - 02/2016
3	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2018 - 02/2008
3	Polyneuropathies (Polyneuropathy) 01/2018 - 02/2008
3	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2018 - 02/2008
3	Cataplexy 06/2017 - 03/2014
3	Dystonia (Limb Dystonia) 12/2015 - 09/2012
3	Deafness (Deaf Mutism) 07/2015 - 02/2008
3	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 02/2013 - 01/2011
2	Autoimmune Diseases of the Nervous System 09/2022 - 01/2021
2	Disease Progression 09/2022 - 06/2020
2	Encephalitis (Encephalitis, Rasmussen) 09/2022 - 12/2018
2	Nervous System Diseases (Neurological Disorders) 08/2022 - 02/2016
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 06/2022 - 11/2020
2	Multiple System Atrophy 05/2022 - 09/2020
2	Tauopathies 01/2022 - 04/2014
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2018
2	Isaacs Syndrome (Neuromyotonia) 08/2021 - 02/2009
2	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 09/2020
2	Channelopathies 01/2021 - 05/2004
2	Movement Disorders (Movement Disorder) 09/2020 - 09/2016
2	Wolfram Syndrome (Syndrome, Wolfram) 06/2020 - 01/2020
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2019 - 01/2019
2	REM Sleep Behavior Disorder 01/2019 - 05/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2016
2	Disorders of Excessive Somnolence (Hypersomnia) 06/2017 - 08/2015
2	CADASIL 03/2016 - 06/2015
2	Pure Autonomic Failure 02/2016 - 02/2013
1	Sleepiness 09/2022
1	Thymoma (Thymic Carcinoma) 09/2022
1	Seizures (Absence Seizure) 05/2022
1	Autoimmune limbic encephalitis 05/2022
1	Paraplegia (Spastic Paraplegia) 04/2022
1	Leigh Disease (Leigh's Disease) 01/2022
1	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 01/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022

Drug/Important Bio-Agent (IBA)

16	SynucleinsIBA 05/2022 - 02/2013
16	Mitochondrial DNA (mtDNA)IBA 01/2022 - 03/2006
12	Proteins (Proteins, Gene)FDA Link 08/2021 - 02/2009
11	AntibodiesIBA 09/2022 - 02/2017
11	Biomarkers (Surrogate Marker)IBA 05/2022 - 02/2013
7	EnzymesIBA 01/2022 - 01/2014
5	OrexinsIBA 06/2017 - 12/2008
4	alpha-Galactosidase (Beano)IBA 01/2022 - 01/2014
4	GalactosidasesIBA 12/2021 - 01/2016
4	Retinaldehyde (Retinal)IBA 01/2020 - 08/2014
3	Calcium Channels (Calcium Channel)IBA 08/2021 - 01/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 05/2011
2	Messenger RNA (mRNA)IBA 08/2022 - 10/2021
2	nusinersenIBA 06/2022 - 11/2020
2	melanopsinIBA 01/2022 - 01/2016
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2016
2	Acetylcarnitine (Alcar)IBA 01/2022 - 01/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 08/2021 - 11/2014
2	CalciumIBA 06/2020 - 01/2020
2	SteroidsIBA 11/2019 - 09/2016
2	Guanosine Triphosphate (GTP)IBA 01/2019 - 12/2015
2	globotriaosylceramide (globotriosylceramide)IBA 01/2019 - 01/2017
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2016 - 09/2007
2	idebenoneIBA 02/2013 - 09/2011
2	A-factor (Streptomyces)IBA 09/2012 - 06/2007
2	Adenosine Triphosphate (ATP)IBA 05/2011 - 01/2011
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 05/2011 - 01/2009
2	Phosphorus (Red Phosphorus)IBA 05/2011 - 01/2011
2	Adrenergic Agents (Adrenergic Drugs)IBA 09/2007 - 02/2006
1	Lacosamide FDA Link 09/2022
1	EpitopesIBA 09/2022
1	anti-titin autoantibodyIBA 09/2022
1	gamma-Aminobutyric Acid (GABA)IBA 09/2022
1	Pharmaceutical PreparationsIBA 09/2022
1	pitolisantIBA 09/2022
1	COVID-19 VaccinesIBA 08/2022
1	sperm releasing substanceIBA 04/2022
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2022

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2011
3	Immunotherapy 04/2021 - 01/2020
2	Transcranial Direct Current Stimulation 09/2019 - 06/2018
2	Enzyme Replacement Therapy 05/2018 - 01/2016
2	Lasers (Laser) 01/2018 - 02/2014
2	Continuous Positive Airway Pressure 09/2007 - 06/2006
1	Immunomodulation 09/2022
1	Drug Prescriptions 09/2022
1	Analgesia 01/2022